Donald A Bergstrom

CIK 1709772 · President, R&D · last filed 2026-01-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.26M

Companies

3

Total Filings

61

Lifetime Open-Market Net

-$10.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RLAY President, R&D 422,733 $14.81 $6.26M -$10.16M 55 2026-01-29
Fusion Pharmaceuticals Inc. (FUSN) Delisted Director $21.55 $0 5 2024-06-04
Mersana Therapeutics, Inc. (MRSN) Delisted Chief Medical Officer $29.08 $0 1 2018-02-06

Recent Filings · Page 4 of 7

61 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-11-01 RLAY Mixed −1,817 -$188.2K EDGAR
2022-10-04 RLAY Mixed -$146.5K EDGAR
2022-09-29 RLAY Sell (S) −976 -$22.2K EDGAR
2022-09-08 RLAY Mixed -$647.0K EDGAR
2022-09-02 RLAY Mixed -$104.6K EDGAR
2022-09-01 RLAY Mixed -$153.5K EDGAR
2022-08-25 RLAY Mixed -$313.2K EDGAR
2022-08-08 RLAY Mixed -$127.0K EDGAR
2022-07-29 RLAY Sell (S) −1,835 -$39.0K EDGAR
2022-07-08 RLAY Mixed -$127.0K EDGAR
Showing 3140 of 61
Page 4 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.